MGNI:NASDAQMagnite, Inc. Analysis
Data as of 2026-05-23 - not real-time
$13.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Magnite (MGNI) trades at $13.20, comfortably above its 20‑day SMA (13.29) but well below the 200‑day SMA (16.32), indicating short‑term momentum against a long‑term downtrend. The RSI sits at 50.7, suggesting a neutral stance, while the MACD histogram is negative and the signal line is bearish, reinforcing short‑term downside pressure. Volatility is elevated at 57% over the past 30 days and beta is about 1.4, highlighting a stock that moves sharply with the market. On the valuation side, the forward PE of 10.7 and trailing PE of 12.6 are markedly below the industry average PE of 17.0, positioning MGNI as undervalued relative to peers, with analysts projecting a median price target of $21 – a potential upside of roughly 68%. Recent earnings showed a 5.5% YoY revenue increase to $164.4 M but missed consensus, yet non‑GAAP EPS of $0.13 beat expectations by 23%, underscoring resilient profitability. The company also announced an AI suite expansion aimed at automating CTV and premium media workflows, a strategic move that could fuel future growth. However, the retirement of CFO David Day introduces short‑term executive transition risk. Overall, the stock sits near its technical support at $12.35, faces high volatility, but benefits from a strong earnings beat, AI‑driven growth prospects, and an attractive valuation gap.
Given the “Extreme Greed” sentiment in the fear‑and‑greed index and a strong analyst consensus of “strong buy,” the medium‑ to long‑term outlook leans bullish, provided the company can sustain its margin profile (gross margin ~63%) and navigate the competitive ad‑tech landscape. Investors should weigh the near‑term technical bearishness against the fundamental upside potential and consider a phased entry strategy.
Given the “Extreme Greed” sentiment in the fear‑and‑greed index and a strong analyst consensus of “strong buy,” the medium‑ to long‑term outlook leans bullish, provided the company can sustain its margin profile (gross margin ~63%) and navigate the competitive ad‑tech landscape. Investors should weigh the near‑term technical bearishness against the fundamental upside potential and consider a phased entry strategy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at $12.35
- Bearish MACD and neutral RSI
- Recent earnings beat on profit but revenue miss
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation relative to industry PE
- AI suite expansion driving future revenue growth
- Analyst price target implying ~68% upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong long‑term tailwinds in CTV and programmatic advertising
- Sustainable gross margin and improving operating efficiency
- Favorable valuation multiples with potential for continued earnings expansion
Key Metrics & Analysis
Financial Health
Revenue Growth5.50%
Profit Margin21.96%
P/E Ratio12.6
ROE19.12%
ROA2.38%
Debt/Equity46.81
P/B Ratio2.1
Op. Cash Flow$112.8M
Free Cash Flow$1.5M
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI50.7
Support$12.35
Resistance$14.32
MA 20$13.29
MA 50$12.76
MA 200$16.32
MACDBearish
VolumeStable
Fear & Greed Index91.61
Valuation
Target Price$22.21
Upside/Downside68.29%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.41
Volatility57.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.